Tibet Pharmaceuticals, Inc. (NASDAQ: TBET) announced on February 27th its intent to accept a “going private” and cease its public company status. Mr. Hong Yu, CEO and Chairman of Tibet Pharmaceuticals, made an offer to purchase TBET stocks not owned by him for $3.00 per share in cash. Mr. Hong Yu commented: “In recent days, […]